Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice.
The biliary excretion of piperacillin has been assessed in 11 patients with obstructive jaundice due to hilar cholangiocarcinoma. After a 1-g intravenous dose administered 30 min before preliminary percutaneous transhepatic cholangiography, no drug was detected in the bile of seven patients; in four...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1985
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180327/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/4083861/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.6.778 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
